Devonian reports additional molecular data from MASH liver study
Global Systems DynamicsGlobal Systems Dynamics(US:GSD) Prnewswire·2026-02-12 14:00
  • -- Devonian reports additional molecular data from MASH liver study [Accessibility Statement] Skip NavigationGene expression analysis from the STAM mouse model attributes Thykamineâ"¢ with dose- dependent anti-MASH, anti-inflammatory and anti-fibrosis molecular effects in liverQUÉBEC, Feb. 12, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) (OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to fibroinflammatory diseases, today annou ...
Global Systems Dynamics-Devonian reports additional molecular data from MASH liver study - Reportify